FibroBiologics, Inc. Common Stock (FBLG)

USD 2.01

(-6.51%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020
Total Assets 11.82 Million 4.82 Million 468 Thousand -
Total Current Assets 9.21 Million 2.62 Million 468 Thousand -
Cash And Short Term Investments 9.16 Million 2.26 Million 407 Thousand -
Cash and Cash Equivalents 9.16 Million 2.26 Million 407 Thousand -
Short Term Investments - - - -
Net Receivables - 300 Thousand - -
Inventory - - - -
Other Current Assets 52 Thousand 59 Thousand 61 Thousand -
Total Non-Current Assets 2.6 Million 2.19 Million - -
Net PPE 2.6 Million 2.19 Million - -
Good Will And Intangible Assets - - - -
Good Will - - - -
Intangible Assets - - - -
Long-Term Investments - - - -
Tax Assets - - - -
Other Non Current Assets - - - -
Other Assets - - - -
Total Liabilities 10.56 Million 8.82 Million 1.75 Million -
Total Current Liabilities 9.18 Million 7.07 Million 1.75 Million -
Account Payables 1.37 Million 493 Thousand 229 Thousand -
Tax Payables - - - -
Short Term Debt 362 Thousand 5.77 Million 1.52 Million -
Deferred Revenue - - - -
Other Current Liabilities 7.44 Million 803 Thousand 4000.00 -
Total Non Current Liabilities 1.38 Million 1.74 Million - -
Long-Term Debt 1.38 Million 1.74 Million - -
Deferred Revenue Non Current - - - -
Deferred Tax Liabilities Non Current - - - -
Other Non Current Liabilities -1.00 - - -
Other Liabilities 1.00 - - -
Total Equity 1.25 Million -3.99 Million -1.29 Million -
Stock Holders Equity 1.25 Million -3.99 Million -1.29 Million -
Common Stock 1000.00 1000.00 - 1.16 Million
Retained Earnings -24.35 Million -7.87 Million -2.75 Million -1.16 Million
Accumulated other comprehensive income - 1.46 Million 1.46 Million -
Common Stock Equity 1.25 Million -3.99 Million -1.29 Million -
Capital Lease Obligation 1.38 Million 1.74 Million - -
Total Investments - - - -
Total Debt 1.74 Million 7.52 Million 1.52 Million -
Net Debt -7.41 Million 5.25 Million 1.11 Million -

Balance Sheet Charts